InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Nicole Labrosse, SVP, CHIEF FINANCIAL OFFICER, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 8 open-market SEC Form 4 transactions: 0 purchases worth $0 and 8 sales worth $3.3M, reported from Nov 15, 22 to Sep 22, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 25 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 1.9K | $78.67 | $149K |
| Sep 10, 25 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 13.2K | $75.93 | $1.0M |
| Jul 22, 24 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 4.0K | $54.25 | $216K |
| Jun 28, 24 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 10.0K | $52.04 | $520K |
| Jun 27, 24 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 10.0K | $51.93 | $519K |
| Jun 26, 24 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 10.0K | $51.82 | $518K |
| Feb 16, 23 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 2.5K | $49.26 | $124K |
| Nov 15, 22 | HALOHALOZYME THERAPEUTICS, INC. | SELL | 4.6K | $53.82 | $249K |